ScreenerHero

HYPD Hyperion DeFi, Inc.

NAS · US · Healthcare · Biotechnology · hyperiondefi.com
3.590USD-6.02%Mkt Cap: 54.58M $P/E: —

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap54.58M USD
Enterprise Value58.64M USD
Revenue (TTM)1.40M USD
Gross Profit510.17K USD
Net Income (TTM)-45.31M USD
Revenue/Share0.14 USD
Last Price3.590 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue41.86
P/S41.46
P/B0.57
EPS (TTM)-6.30
EPS (Forward)—
52W Range
2.34013% of range11.89
52W High11.89 USD
52W Low2.340 USD
Profitability
Gross Margin62.72%
Oper. Margin-757.51%
EBITDA Margin0.00%
Profit Margin-5570.61%
ROE-110.36%
ROA-87.54%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.77M USD
CapEx (TTM)71.95M USD
FCF Margin-1056.90%
FCF Yield-27.13%
Net Debt-725.30K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.21
Current Ratio2.34
Quick Ratio1.82
Book Value/Sh6.66 USD
Cash/Share0.62 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:80
Split DateFeb 3, 2025
Analyst Consensus
Rating—
Target (Mean)9.825 USD
Upside (mean)+173.7%
Target Range8.450 USD – 11.20 USD
8.450+173.7% to mean11.20
# Analysts2
Ownership
Shares Out.15.20M
Float13.75M
Insiders13.79%
Institutions18.72%
Short Interest
Short Ratio1.8d
Short % Float8.24%
Short % Out.7.99%
Shares Short1.24M
Short (prev mo.)1.54M
Technical
SMA 503.248 (+10.5%)
SMA 2003.397 (+5.7%)
Beta2.52
S&P 52W Chg16.45%
Avg Vol (30d)591.02K
Avg Vol (10d)526.68K
Technical Indicators
RSI (14)49.5
MACD0.1456
MACD Signal0.1985
MACD Hist.-0.0529
BB Upper4.202 USD
BB Middle3.775 USD
BB Lower3.347 USD
BB Width22.67%
ATR (14)0.2800 USD
Vol Ratio (20d)0.64x